Christopher M. Longshaw, PhD

Senior Director, Scientific Affairs EU
Shionogi B.V.
London, England, United Kingdom

Disclosure information not submitted.

Presentation(s):

• 627 - β-lactam-β-lactamase Inhibitor Combinations Show a High Degree of Cross Resistance in Gram-negative Bacteria But Not to Cefiderocol; Results from the SENTRY Antimicrobial Surveillance Program (2020-2024)

  Wednesday, October 22, 2025
  1:57 PM - 2:09 PM US ET